Xenon Pharmaceuticals Inc’s recently made public that its Director GAROFALO ELIZABETH A. unloaded Company’s shares for reported $95583.0 on Mar 08 ’24. In the deal valued at $45.69 per share,2,092 shares were sold. As a result of this transaction, GAROFALO ELIZABETH A. now holds 0 shares worth roughly $0.0.
Then, GANNON STEVEN sold 13,000 shares, generating $601,615 in total proceeds. Upon selling the shares at $46.28, the Director now owns 2,000 shares.
Before that, ROBIN SHERRINGTON sold 7,137 shares. Xenon Pharmaceuticals Inc shares valued at $330,290 were divested by the EVP, Strategy & Innovation at a price of $46.28 per share. As a result of the transaction, ROBIN SHERRINGTON now holds 8,398 shares, worth roughly $0.36 million.
Citigroup initiated its Xenon Pharmaceuticals Inc [XENE] rating to a Buy in a research note published on January 04, 2024; the price target was $62. A number of analysts have revised their coverage, including Robert W. Baird’s analysts, who began to cover the stock in early December with a ‘”an Outperform”‘ rating. Cantor Fitzgerald started covering the stock on April 25, 2023. It rated XENE as “an Overweight”.
Price Performance Review of XENE
On Tuesday, Xenon Pharmaceuticals Inc [NASDAQ:XENE] saw its stock jump 0.96% to $43.03. Over the last five days, the stock has gained 3.76%. Xenon Pharmaceuticals Inc shares have fallen nearly -6.58% since the year began. Nevertheless, the stocks have risen 22.45% over the past one year. While a 52-week high of $50.99 was reached on 03/01/24, a 52-week low of $27.99 was recorded on 04/03/24. SMA at 50 days reached $45.72, while 200 days put it at $39.60. A total of 0.2 million shares were traded, compared to the trading of 0.46 million shares in the previous session.
Levels Of Support And Resistance For XENE Stock
The 24-hour chart illustrates a support level at 42.63, which if violated will result in even more drops to 42.24. On the upside, there is a resistance level at 43.25. A further resistance level may holdings at 43.48. The Relative Strength Index (RSI) on the 14-day chart is 45.22, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.06, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 46.35%. Stochastics %K at 43.32% indicates the stock is a holding.
How much short interest is there in Xenon Pharmaceuticals Inc?
A steep rise in short interest was recorded in Xenon Pharmaceuticals Inc stocks on Mar 15, 2024, growing by 90000.0 shares to a total of 2.62 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 2.53 million shares. There was a rise of 3.44%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 3.49% of the overall stock float, the days-to-cover ratio (short ratio) rose to 6.48.
The most recent change occurred on December 14, 2022 when Goldman began covering the stock and recommended ‘”a Buy”‘ rating along with a $60 price target.
